Understanding Antibody Responses to Schistosoma haematobium
Author Information
Author(s): Francisca Mutapi, Colin Bourke, Yvonne Harcus, Nicholas Midzi, Tafadzwa Mduluza, Caroline M. Turner, Richard Burchmore, Richard M. Maizels
Primary Institution: Institute of Immunology & Infection Research, School of Biological Sciences, University of Edinburgh
Hypothesis
What are the recognition patterns of different human antibody isotypes against Schistosoma haematobium antigens?
Conclusion
The study found that different antibody isotypes recognize distinct patterns of Schistosoma haematobium antigens, which may inform vaccine development.
Supporting Evidence
- IgG1 recognized the largest number of antigens, followed by IgE and IgA, while IgG4 detected the fewest.
- The prevalence of S. haematobium infection in participants was 57%, with a mean infection intensity of 36 eggs/10 mL urine.
- Participants with higher IgE/IgG4 ratios had lower levels of schistosome infection.
- Three of the World Health Organisation’s 10 schistosome vaccine candidates were recognized by all isotypes tested.
Takeaway
This study looked at how different types of antibodies in humans recognize parts of a parasite that causes schistosomiasis, which can help in making better vaccines.
Methodology
The study used two-dimensional gel electrophoresis and western blotting to analyze antibody responses to Schistosoma haematobium antigens in serum samples from participants.
Potential Biases
Potential bias in participant selection as only those who had never been treated for helminth infections were included.
Limitations
The study focused only on specific age groups and may not represent all demographics affected by schistosomiasis.
Participant Demographics
Participants were aged 7 to 18 years, with a balanced gender distribution (110 men and 105 women).
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website